4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001834411-26-000002
Options or other derivatives
- Chief Financial Officer acquired 808,898 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Booth Andrew Chief Financial Officer | 2026-01-01 | Grant or award · Share option (right to buy) | +808,898 | 8,751,849 | D | ||
Loading xslF345X05/wk-form4_1767633111.xml…